Scotland · NHS Scotland MSAN
Medicine in short supply: Ongentys® (opicapone) 50mg For action
MSAN(2019)8 · Level 3 · issued 28 Oct 2019
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| are currently anticipated mid-January 2020, however exact dates are still to be confirmed. | Resupply date to be confirmed | — |
| by the specialist. The following alternative treatments are available: | Available | — |
| * Caution: increased risk of hepatotoxicity; discontinue if abnormal liver function tests or | Discontinued | — |
| symptoms of liver disorder; do not re-introduce tolcapone once discontinued. | Discontinued | — |
| impact) therapeutic class are available but which may likely to require a change in the class | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2019:8
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
e2f122eba782ad3205457050788a9dcdf0577a065f9b310bbee5a333e44a91adsha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2019-08.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.